Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Weinhage, , Stephen,
DOB: 11-AUG-1950 (Age: 75)
Gender: male
Address:
Bertold-Stahr-Platz 6/3
31535 Neustadt am Rübenberge (Germany)
ID: 6413-101438-9 (ECI)
Report
Date: 09-MAY-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Landarztpraxis Dudensen
Dudenser Straße 41A
31535 Neustadt am Rübenberge (Germany)
Specimen
Collected: 09-MAY-2022

Chemistry

Test 09-MAY-2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.9 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 100.5 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.0 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 136.1 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.7 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.1 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 205.4 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 156.0 H 40 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 115.2 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 59.0 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 13.5 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c, indicating suboptimal long-term glycemic control (diabetes). Cholesterol and triglycerides are mildly elevated, suggesting increased cardiovascular risk. Renal function, electrolytes, and urine microalbumin/creatinine ratio are within normal limits. Continued monitoring and optimization of diabetes and lipid management are recommended.